Supriya Lifescience

631.70
+5.40
(0.86%)
Market Cap
5,084.10 Cr
EPS
14.80
PE Ratio
28.92
Dividend Yield
0.13 %
Industry
Healthcare
52 Week High
835.20
52 Week low
305.50
PB Ratio
5.57
Debt to Equity
0.02
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from1 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy100.00 %
100.00 %
Hold0.0 %
0.0 %
Sell0.0 %
0.0 %
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,662.85 3,98,973.42 33.68 49,887.20 12.06 9,648 13.77 47.46
5,507.55 1,46,208.15 71.18 8,184.00 0.89 1,600 64.53 40.99
1,453.00 1,17,346.32 23.41 26,520.70 14.17 4,155 47.38 48.78
3,074.60 1,04,058.43 55.61 10,785.70 11.59 1,656 13.54 47.28
1,096.90 91,526.53 17.35 28,905.40 12.36 5,578 1.69 31.30
1,963.10 89,556.14 31.45 20,141.50 19.94 1,936 38.82 44.40
2,170.00 89,527.02 44.67 10,615.60 19.57 1,942 -16.38 33.38
887.00 89,252.95 19.97 19,831.50 13.82 3,831 29.92 45.15
30,389.70 64,575.99 48.58 6,097.20 10.80 1,201 16.01 58.42
1,110.10 64,474.79 17.97 29,559.20 17.55 3,169 -10.04 42.48
Growth Rate
Revenue Growth
23.51 %
Net Income Growth
32.48 %
Cash Flow Change
78.13 %
ROE
13.70 %
ROCE
13.74 %
EBITDA Margin (Avg.)
7.41 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
140
172
191
222
286
323
396
538
470
581
680
Expenses
121
150
166
191
213
213
218
316
332
397
422
EBITDA
20
22
25
31
73
110
178
222
138
184
258
Operating Profit %
12 %
12 %
9 %
10 %
23 %
32 %
44 %
40 %
28 %
30 %
37 %
Depreciation
3
4
5
5
5
6
7
10
12
16
18
Interest
7
10
12
11
10
7
4
4
3
2
2
Profit Before Tax
10
8
8
15
57
96
167
207
124
166
238
Tax
2
2
2
6
18
23
44
55
34
47
53
Net Profit
8
6
6
9
39
73
124
152
90
119
175
EPS in ₹
16.82
3.89
3.87
1.19
5.39
10.02
16.89
18.86
11.16
14.80
21.70

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
176
231
241
245
253
336
446
735
820
921
Fixed Assets
61
76
89
91
85
99
100
190
262
310
Current Assets
103
129
115
120
133
196
266
498
465
398
Capital Work in Progress
11
25
36
34
35
40
79
43
68
149
Investments
0
0
0
0
0
0
0
0
25
64
Other Assets
104
131
117
120
133
197
267
502
466
399
Total Liabilities
176
231
241
245
253
336
446
735
820
921
Current Liabilities
115
150
144
146
135
155
146
100
96
77
Non Current Liabilities
23
39
51
45
24
32
31
19
25
29
Total Equity
37
42
46
55
94
149
269
616
700
815
Reserve & Surplus
33
26
31
40
79
134
254
600
683
799
Share Capital
5
15
15
15
15
15
15
16
16
16

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
1
2
-2
3
4
62
15
139
-70
-83
Investing Activities
-23
-33
-27
-5
5
-25
-47
-60
-124
-174
Operating Activities
-6
14
27
28
49
117
76
49
64
113
Financing Activities
30
21
-2
-20
-50
-29
-15
150
-10
-22

Share Holding

% Holding
May 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
99.98 %
68.24 %
68.24 %
68.24 %
68.24 %
68.24 %
68.28 %
68.30 %
68.30 %
68.30 %
68.30 %
68.30 %
68.30 %
68.30 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
5.34 %
0.00 %
5.36 %
4.95 %
6.03 %
6.52 %
DIIs
0.00 %
5.20 %
4.72 %
7.27 %
6.23 %
7.89 %
7.65 %
7.55 %
7.17 %
3.85 %
5.30 %
5.48 %
5.45 %
4.92 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
8.25 %
12.73 %
12.52 %
13.40 %
15.07 %
15.54 %
15.39 %
16.10 %
17.50 %
17.06 %
17.19 %
0.00 %
16.28 %
Others
0.02 %
18.30 %
14.31 %
11.97 %
12.13 %
8.80 %
8.53 %
8.76 %
3.09 %
10.35 %
3.98 %
4.08 %
20.23 %
3.98 %
No of Share Holders
7
50,506
82,578
86,853
94,594
96,998
95,605
93,478
92,991
95,929
87,980
89,621
85,328
89,394

Dividend History

Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Announcements

Details Of Key Managerial Personnel Under Regulation 30(5) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
1 day ago
Announcement under Regulation 30 (LODR)-Change in Management
1 day ago
Appointment of Company Secretary and Compliance Officer
1 day ago
Board Meeting Outcome for Outcome Of Board Meeting Held To Consider Appointment Of Company Secretary And Compliance Officer Of The Company.
1 day ago
Board Meeting Intimation for Appointment Of Company Secretary And Compliance Officer Of The Company
6 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 26, 2025, 16:26
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 26, 2025, 16:26
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 26, 2025, 16:22
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 26, 2025, 16:22
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 26, 2025, 16:20
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 26, 2025, 16:20
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 25, 2025, 13:10
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 25, 2025, 13:10
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 18, 2025, 17:09
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 10, 2025, 14:22
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 10, 2025, 14:19
Announcement under Regulation 30 (LODR)-Change in Directorate
Feb 01, 2025, 14:35
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Jan 31, 2025, 12:40
Announcement under Regulation 30 (LODR)-Newspaper Publication
Jan 27, 2025, 16:09
Audio Recording Of Earnings Call
Jan 27, 2025, 16:07
Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)
Jan 27, 2025, 10:08
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Jan 25, 2025, 11:38
Announcement under Regulation 30 (LODR)-Investor Presentation
Jan 24, 2025, 21:44
Integrated Filing (Financial)
Jan 24, 2025, 21:37
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Jan 24, 2025, 17:19
Details Of Key Managerial Personnel Under Regulation 30(5) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
Jan 24, 2025, 17:09
Announcement under Regulation 30 (LODR)-Change in Directorate
Jan 24, 2025, 17:01
Unaudited Financial Results For The Quarter And Nine Month Ended December 31 2024
Jan 24, 2025, 16:24
Board Meeting Outcome for Outcome Of Board Meeting In Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
Jan 24, 2025, 16:17
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Jan 17, 2025, 17:16
Board Meeting Intimation for Regulation 29(1) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
Jan 16, 2025, 17:14
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Jan 07, 2025, 15:13
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Jan 02, 2025, 15:10
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Jan 02, 2025, 14:19
Intimation Of Change In Name Of RTA
Jan 02, 2025, 11:46
Reply To Clarification On News Item Appearing In "Media/Publication
Jan 01, 2025, 15:12
Clarification sought from Supriya Lifescience Ltd
Jan 01, 2025, 14:59
Closure of Trading Window
Dec 30, 2024, 17:07
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Dec 30, 2024, 14:47
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Dec 17, 2024, 16:28
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Dec 17, 2024, 15:25
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Dec 11, 2024, 12:38
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Dec 09, 2024, 14:44
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Nov 28, 2024, 17:35
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Nov 28, 2024, 12:15
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Nov 07, 2024, 11:16
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Nov 06, 2024, 13:02
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Nov 04, 2024, 15:17
Announcement under Regulation 30 (LODR)-Newspaper Publication
Oct 29, 2024, 12:16
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Oct 28, 2024, 21:40

Company Filings to Exchanges

Technical Indicators

RSI(14)
Neutral
44.61
ATR(14)
Less Volatile
42.67
STOCH(9,6)
Neutral
54.03
STOCH RSI(14)
Neutral
77.89
MACD(12,26)
Bullish
0.73
ADX(14)
Weak Trend
20.11
UO(9)
Bearish
48.88
ROC(12)
Downtrend And Accelerating
-1.32
WillR(14)
Neutral
-48.27